All Type of News
Drugmakers, wholesalers to cooperate
The Korea Pharmaceutical Manufacturers Association and the Korea Association of Pharmaceutical Wholesaler agreed to work together over the current issues.
The agreement was reached during the meeting between KPMA c...
Novartis AG leads world’s pharmaceutical market by 2015
Novartis AG, one of the largest pharmaceutical companies in the world, is expected to play a pivotal role in its performance in the ethical pharmaceutical sector against key rivals, posting impressive forecast sales C...
Bioequivalence guideline for capecitabine makes public
The Korea Food and Drug Administration has published a new bioequivalence guideline for capecitabine tablets, defining that generic makers should conduct the above testing in patients with colorectal cancers breast ca...
CJ releases adefovir pivoxil in amorphous form
CJ Cheil Jedang says it has launched adefovir pivoxil in amorphous form, which does not infringe the original patent of GlaxoSmithKline.
CJ’s new formulation is characterized by reverse chromatography and solid dis...
Boehringer Ingelheim Korea introduces Buscopan
The newly launched online website of Boeringer Ingelheim Korea has introduced convulsive stomach pain in more detail for its visitors.
Its official website at http://edu.buscopan.co.kr provides information on the B...
Drugmakers enjoy few rewards for innovation
The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharmaceutical R&D investment is very long-term and carries a significant...
KFDA to strengthen on-spot inspection
The Korea Food and Drug Administration plans to undertake its on-spot inspection on the manufacturing facilities of imported drugs overseas in a bid to prevent the importation of any sub-substandard products.
To t...
KFDA builds clinical database
The Korea Food and Drug Administration said on June 30 it has established a comprehensive database incorporating a total of 600 clinical trials worldwide.
The drug agency said it has compiled comprehensive clinical...
Yuyu signs $3 million export deal over Maxmarvil
Yuyu Pharm said on June 28 it inked a $3 million export deal with an importer of Myanmar for its in-house developed osteoporosis drug Maxmarvil tablets (alendronate+calcitriol).
“We believe that if Maxmarvil makes...
Cho nominated as President of Support Committee for IVI
Cho Dong-sung, incumbent professor of Seoul National University was nominated as new president of Support Committee for the International Vaccine Institute (IVI), it was learned on June 29.
Cho will replace Lee San...
